Literature DB >> 9049817

Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods.

A T Bernards1, A J de Beaufort, L Dijkshoorn, C P van Boven.   

Abstract

Septicaemia caused by Acinetobacter occurred in six infants in the neonatal unit. A total of 18 acinetobacters were isolated from blood cultures, cultures of intravascular catheters, and surveillance cultures. Twelve isolates from the six affected infants were identified as Acinetobacter junii by the use of a novel method, amplified ribosomal DNA restriction analysis (ARDRA). Typing of the organisms using the biochemical profiles of the API 20NE system, antibiogram typing, cell envelope protein electrophoresis, and PCR fingerprinting with two primer sets, ERIC1/ERIC2 and ERIC2/ 1026, showed that these 12 isolates were indistinguishable, whereas the remaining six isolates were different. The six infants recovered after therapy with ciprofloxacin alone in five cases and with a combination of ciprofloxacin and gentamicin in one case. This study showed that A. junii is capable of causing a serious, though non-fatal infection in neonates. The combined use of genotypic and phenotypic methods allowed the rapid separation of epidemic from non-epidemic isolates. It is concluded that for a better understanding of the role of the various Acinetobacter genomic species in human pathology, identification of acinetobacters according to the recent taxonomy is imperative.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049817     DOI: 10.1016/s0195-6701(97)90101-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  9 in total

1.  Neonatal gram-negative bacteremia.

Authors:  S G Joshi; V S Ghole; K B Niphadkar
Journal:  Indian J Pediatr       Date:  2000-01       Impact factor: 1.967

2.  Association of the genus Acinetobacter with the decomposition of a swine carcass and the isolation and characterization of a novel strain of Acinetobacter sp. P4.

Authors:  Gary T Howard; William N Norton; Peter G Stroot; Kathryn L Bailey; Erin J Watson
Journal:  Curr Microbiol       Date:  2011-10-11       Impact factor: 2.188

3.  Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens.

Authors:  A Nemec; L Dijkshoorn; P Jezek
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  Identification of Acinetobacter isolates from species belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with monoclonal antibodies specific for O Antigens of their lipopolysaccharides.

Authors:  Ralph Pantophlet; Juliëtte A Severin; Alexandr Nemec; Lore Brade; Lenie Dijkshoorn; Helmut Brade
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

5.  Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates.

Authors:  A Jawad; H Seifert; A M Snelling; J Heritage; P M Hawkey
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

6.  Septicemia due to Acinetobacter junii.

Authors:  Hans-Jörg Linde; Joachim Hahn; Ernst Holler; Udo Reischl; Norbert Lehn
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

7.  Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey.

Authors:  P J van den Broek; T J K van der Reijden; E van Strijen; A V Helmig-Schurter; A T Bernards; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

8.  Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.

Authors:  H-Y Tsai; A Cheng; C-Y Liu; Y-T Huang; Y-C Lee; C-H Liao; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-06       Impact factor: 3.267

9.  Molecular characterization and antimicrobial susceptibility of bacterial isolates present in tap water of public toilets.

Authors:  Rajanbir Kaur; Drishtant Singh; Anup Kumar Kesavan; Rajinder Kaur
Journal:  Int Health       Date:  2020-09-01       Impact factor: 2.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.